IDH2 and angioimmunoblastic T-cell lymphoma: The patient showed shared TET2 and DNMT3A mutations in sorted neoplastic T-cells and bulk peripheral blood, with RHOA p.G17V and IDH2 p.R172K mutations in the AITL cells.